Home » Trials » SLCTR/2021/022 » Progress Reports
Date Modified
2023-08-12
Period
12/months
Report Summary
• Trial commenced on 01.08.2021. • Final sample size: 208 • Date of trial completion: 15.02.2022. * In conclusion, 50 mcg misoprostol three doses, 4 hours apart resulted in reducing the delivery time and lesser chance of emergency LSCS. Misoprostol intervention group resulted in fewer obstetric and neonatal complications compared with the dinoprostone group. In the future, larger-scale studies should be carried out to elucidate the dose-dependent efficiency of misoprostol over dinoprostone.